Salivary gland carcinosarcoma: Oligonucleotide array CGH reveals similar genomic profiles in epithelial and mesenchymal components

Oral Oncology

Volumn 45, Issue 3, 2009, Pages 259-265

  Vékony, Hedy ^a   Leemans, C René ^b   Ylstra, Bauke ^b   Meijer, Gerrit A ^b   van der Waal, Isaäc ^a   Bloemena, Elisabeth ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Carcinosarcoma; Gene copy number; Genomic instability; Salivary gland neoplasms

Indexed keywords

BMI1 PROTEIN; DNA; MUCIN; MUCIN 20; UNCLASSIFIED DRUG; BMI1 PROTEIN, HUMAN; MUC20 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; POLYCOMB GROUP PROTEIN; REPRESSOR PROTEIN;

ADULT; ARTICLE; CARCINOSARCOMA; CASE REPORT; CHROMOSOME ABERRATION; CLONAL VARIATION; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; FEMALE; GENE LOCUS; GENE LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESENCHYME; MOUTH MUCOSA; PAROTID GLAND CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; COPY NUMBER VARIATION; GENETICS; GENOMIC INSTABILITY; METABOLISM; MIDDLE AGED; PAROTID GLAND TUMOR; PROCEDURES;

CARCINOSARCOMA; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; FEMALE; GENOMIC INSTABILITY; HUMANS; MIDDLE AGED; MUCINS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAROTID NEOPLASMS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; POLYCOMB REPRESSIVE COMPLEX 1; POLYCOMB-GROUP PROTEINS;

EID: 60249089467     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.05.009     Document Type: Article

References (31)

1. King Jr. O.H. Carcinosarcoma of accessory salivary gland. First report of a case. Oral Surg Oral Med Oral Pathol 23 5 (1967) 651-659
2. Gnepp D.R. Malignant mixed tumors of the salivary glands: a review. Pathol Annu 28 Part 1 (1993) 279-328
3. In: Barnes L., Eveson J.W., Reichart P., and Sidransky D. (Eds). World health organization classification of tumours: pathology and genetics of head and neck tumours (2005), IARC Press, Lyon p. 244
4. Gotte K., Riedel F., Coy J.F., Spahn V., and Hormann K. Salivary gland carcinosarcoma: immunohistochemical, molecular genetic and electron microscopic findings. Oral Oncol 36 4 (2000) 360-364
5. Pang P.C., To E.W., Tsang W.M., and Liu T.L. Carcinosarcoma (malignant mixed tumor) of the parotid gland: a case report. J Oral Maxil Surg 59 5 (2001) 583-587
6. Stephen J., Batsakis J.G., Luna M.A., Von der H.U., and Byers R.M. True malignant mixed tumors (carcinosarcoma) of salivary glands. Oral Surg Oral Med Oral Pathol 61 6 (1986) 597-602
7. Rossi G., Cavazza A., Sturm N., Migaldi M., Facciolongo N., Longo L., et al. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol 27 3 (2003) 311-324
8. Matsumoto T., Fujii H., Arakawa A., Yamasaki S., Sonoue H., Hattori K., et al. Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma. Hum Pathol 35 3 (2004) 322-327
9. Thompson L., Chang B., and Barsky S.H. Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol 20 3 (1996) 277-285
10. Fowler M.H., Fowler J., Ducatman B., Barnes L., and Hunt J.L. Malignant mixed tumors of the salivary gland: a study of loss of heterozygosity in tumor suppressor genes. Mod Pathol 19 3 (2006) 350-355
11. Volker H.U., Muhlmeier G., Maier H., Kraft K., Muller-Hermelink H.K., and Zettl A. True malignant mixed tumour (carcinosarcoma) of submandibular gland - a rare neoplasm of monoclonal origin. Histopathology 50 6 (2007) 795-798
12. Staffieri C., Marioni G., Ferraro S.M., Marino F., and Staffieri A. Carcinosarcoma de novo of the parotid gland. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 2 (2007) e35-e40
13. Gandour-Edwards R.F., Donald P.J., Vogt P.J., Munn R., and Min K.W. Carcinosarcoma (malignant mixed tumor) of the parotid: report of a case with a pure rhabdomyosarcoma component. Head Neck 16 4 (1994) 379-382
14. Pinkel D., and Albertson D.G. Array comparative genomic hybridization and its applications in cancer. Nat Genet 37 Suppl. (2005) S11-S17
15. Jong K., Marchiori E., Van der Vaart A., Chin S.F., Carvalho B., Tijssen M., et al. Cross-platform array comparative genomic hybridization meta-analysis separates hematopoietic and mesenchymal from epithelial tumors. Oncogene 26 10 (2007) 1499-1506
16. Van den IJssel P., and Ylstra B. Oligonucleotide array comparative genomic hybridization. Meth Mol Biol 396 (2007) 207-222
17. Buffart T.E., Tijssen M., Krugers T., Carvalho B., Smeets S.J., Brakenhoff R.H., et al. DNA quality assessment for array CGH by isothermal whole genome amplification. Cell Oncol 29 4 (2007) 351-359
18. Coe B.P., Ylstra B., Carvalho B., Meijer G.A., MacAulay C., and Lam W.L. Resolving the resolution of array CGH. Genomics 89 5 (2007) 647-653
19. Olshen A.B., Venkatraman E.S., Lucito R., and Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5 4 (2004) 557-572
20. Van de Wiel M.A., Kim K.I., Vosse S.J., Van Wieringen W.N., Wilting S.M., and Ylstra B. CGHcall: calling aberrations for array CGH tumor profiles. Bioinformatics 23 7 (2007) 892-894
21. Tortoledo M.E., Luna M.A., and Batsakis J.G. Carcinomas ex pleomorphic adenoma and malignant mixed tumors. Histomorphologic indexes. Arch Otolaryngol 110 3 (1984) 172-176
22. Ellis G.L., and Auclair P.L. Tumors of the salivary glands. Atlas of tumor pathology, 3rd series, fasicle 17 (1996), Armed Forces Institute of Pathology, Washington, DC p. 259-260
23. Torenbeek R., Hermsen M.A., Meijer G.A., Baak J.P., and Meijer C.J. Analysis by comparative genomic hybridization of epithelial and spindle cell components in sarcomatoid carcinoma and carcinosarcoma: histogenetic aspects. J Pathol 189 3 (1999) 338-343
24. Teixeira M.R., Qvist H., Bohler P.J., Pandis N., and Heim S. Cytogenetic analysis shows that carcinosarcomas of the breast are of monoclonal origin. Gene Chromosome Canc 22 2 (1998) 145-151
25. Gronau S., Menz C.K., Melzner I., Hautmann R., Moller P., and Barth T.F. Immunohistomorphologic and molecular cytogenetic analysis of a carcinosarcoma of the urinary bladder. Virchows Arch 440 4 (2002) 436-440
26. Adam P., Zettl A., Zollner U., Dietl J., Muller-Hermelink H.K., and Eck M. Metastasizing vulvar carcinosarcoma with squamous carcinomatous and leiomyosarcomatous differentiation: genetic evidence of clonal origin. Hum Pathol 36 10 (2005) 1143-1147
27. Vlad A.M., Diaconu I., and Gantt K.R. MUC1 in endometriosis and ovarian cancer. Immunol Res 36 1-3 (2006) 229-236
28. Singh A.P., Chaturvedi P., and Batra S.K. Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy. Cancer Res 67 2 (2007) 433-436
29. Woenckhaus M., Merk J., Stoehr R., Schaeper F., Gaumann A., Wiebe K., et al. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer. Hum Pathol 39 1 (2008) 126-136
30. Raaphorst F.M. Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors. Hum Mol Genet 14 (2005) R93-R100 (Suppl 1)
31. Vékony H., Raaphorst F.M., Otte A.P., Van Lohuizen M., Leemans C.R., Van der Waal I., et al. High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma. J Clin Pathol 61 6 (2008) 744-749